James Nolan

Dr. James Nolan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2022 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
JNJames Nolan
James Nolan
CMCatherine Murphy
Catherine Murphy
KDKate Dinneen
Kate Dinneen
GLGreg Lee
Greg Lee
EHElizabeth Higgins
Elizabeth Higgins
EVElisabeth Vandenberghe
Elisabeth Vandenberghe
Mantle cell lymphoma (MCL) is a B-cell non-Hodgkin lymphoma (B-NHL) with a number of clinically relevant pathological subtypes including ‘indolent’, classical, blastoid and pleomorphic, associated ...

14 November 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
NONiamh O'Flaherty
Niamh O'Flaherty
LBLouise Bryce
Louise Bryce
JNJames Nolan
James Nolan
MLMark David Lambert
Mark David Lambert
Bacterial contamination of platelet components (PC) poses the greatest microbial risk to recipients, as bacteria can multiply over the course of PC storage at room temperature. Between 2010 and 2020, the Irish Blood Transfusion Service (IBTS) screened over 170,000 buffy coat-derived pooled (BCDP) and single-donor apheresis platelets (SDAPs) with the BACT/ALERT 3D microbial detection system (Biomerieux, L’Etoile, France), using a two-step screening protocol which incorporated primary and secondary cultures. Although the protocol was successful in averting septic transfusion reactions (STRs), testing large sample volumes at later time points was reported to improve detection of bacterial contamination. A modified large-volume delayed sampling (LVDS)-type protocol was adopted in 2020, which in the case of SDAP was applied to collections rather than individual splits (2020–2023, 44,642 PC screened). Rates of bacterial contamination for BCDP were 0.125% on Day-2, 0.043% on Day-4 vs. 0.191% in the post-LVDS period. SDAP contamination rates in the pre-LVDS period were 0.065% on Day-1, 0.017% on Day-4 vs. 0.072% in the post-LVDS period. Confirmed STRs were absent, and the interdiction rate for possibly contaminated SDAP was over 70%. In the post-LVDS period, BCDPs had a higher total positivity rate than SDAPs, 0.191% (1:525) versus 0.072% (1:1385), respectively, (chi-squared 12.124, 1 df, p = 0.0005). The majority of organisms detected were skin-flora-type, low pathogenicity organisms, including coagulase-negative staphylococci and Cutibacterium acnes, with little change in the frequency of clinically significant organisms identified over time. Both protocols prevented the issue of potentially harmful components contaminated (rarely) with a range of pathogenic bacteria, including Escherichia coli, Serratia marcesens, Staphylococcus aureus, and streptococci. Culture positivity of outdates post-LVDS whereby 100% of expired platelets are retested provides a residual risk estimate of 0.06% (95% CI 0.016–0.150). However, bacterial contamination rates in expired platelets did not demonstrate a statistically significant difference between the pre-LVDS 0.100% (CI 0.033–0.234) and post-LVDS 0.059% (0.016–0.150) periods (chi-squared = 0.651, 1 df, p = 0.42).

1 August 2020 in Gastroenterology
Verified
Journal Article
Open access
PDF file
EYEdward Young
Edward Young
JNJames Nolan
James Nolan
JAJohn Argyrides
John Argyrides

15 October 2025 in bioRxiv
Verified
Preprint
Open access
DADaniel Angelov
Daniel Angelov
JNJames Nolan
James Nolan
GHGrainne Holland
Grainne Holland
DNDarragh Nimmo
Darragh Nimmo
MDMolly Davies
Molly Davies
ABAdrian P. Bracken
Adrian P. Bracken
SUMMARY: The catalytic subunit of Polycomb Repressive Complex 2 (PRC2), EZH2, is recurrently mutated in 25% of diffuse large B-cell lymphomas (DLBCL), causing increased H3K27me3 and decreased H3K27me2 levels. EZH2 inhibitors provide clinical benefit, but resistance frequently develops, highlighting the need for alternative therapeutic targets. Here, we identify the PRC2 accessory protein AEBP2 as a specific genetic dependency in EZH2-mutant DLBCL. While AEBP2 acts through PRC2, its essential role is surprisingly independent of canonical H3K27me3-mediated gene silencing. Instead, AEBP2 functions within a PRC2.2 complex lacking JARID2, using its zinc-finger domains to sample intergenic chromatin to sustain H3K27me2. Notably, loss of AEBP2 or NSD2 caused contrasting changes in intergenic H3K27me2 levels, driving sensitivity or resistance to PRC2 inhibitors, respectively. Our findings identify AEBP2-PRC2.2-maintained intergenic H3K27me2 as a therapeutic vulnerability in EZH2-mutant DLBCL and highlight dysregulated H3K27me2 as an underappreciated form of PRC2 dysfunction in cancer, with important therapeutic implications.

20 November 2025 in JACC: Case Reports
Verified
Journal Article
Open access
RKRyan Karlsson
Ryan Karlsson
CHConal Houstoun
Conal Houstoun
MBMicheal Brennan
Micheal Brennan
RMRoss T. Murphy
Ross T. Murphy
EVElisabeth Vandenberghe
Elisabeth Vandenberghe
JNJames Nolan
James Nolan
Clinically apparent cardiac involvement in mycosis fungoides (MF) is a rare phenomenon. A 61-year-old man presented with dyspnea 11 months after allogeneic hematopoietic stem cell transplantation for MF. Echocardiography revealed a large pericardial effusion causing cardiac tamponade. Emergency pericardiocentesis and effusion analysis confirmed disease relapse isolated to the pericardium in the setting of full donor chimerism. Despite reduction in immunosuppression, relapse with cardiac tamponade later recurred. Combined-modality chemotherapy and radiotherapy was administered. Systemic disease relapse occurred 22 months after isolated pericardial relapse. This unique case of life-threatening isolated cardiac involvement in relapsed MF exposes the heart as a potential sanctuary site that may sequester lymphoma cells from systemic therapies and the graft-versus-lymphoma effect. Optimal management of this rare complication is unknown. Pericardial or myocardial infiltration should be considered in patients with MF presenting with cardiac symptoms, conduction disturbance, or shock.